Olmesartan Side Effects
Medically reviewed by Drugs.com. Last updated on Oct 26, 2022.
Applies to olmesartan: oral extemporaneous suspension, oral tablets.
Warning
Side effects include:
Dizziness, back pain, bronchitis, diarrhea, headache, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection.
For Healthcare Professionals
Applies to olmesartan: oral tablet.
General
The most common side effect in adults was dizziness.[Ref]
Nervous system
Common (1% to 10%): Dizziness, headache[Ref]
Respiratory
Common (1% to 10%): Bronchitis, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, coughing, nasopharyngitis, pharyngolaryngeal pain, rhinorrhea[Ref]
Other
Common (1% to 10%): Influenza-like symptoms, chest pain, fatigue, peripheral edema, pain, inflicted injury, fever
Uncommon (0.1% to 1%): Vertigo, asthenia, malaise
Rare (less than 0.1%): Lethargy[Ref]
Gastrointestinal
Common (1% to 10%): Diarrhea, gastroenteritis, nausea, tooth ache, abdominal pain, vomiting, dyspepsia
Uncommon (0.1% to 1%): Dyspepsia
Very rare (less than 0.01%): Sprue-like enteropathy[Ref]
Musculoskeletal
Common (1% to 10%): Back pain, creatine phosphokinase increased, gout, arthralgia, arthritis, skeletal pain
Uncommon (0.1% to 1%): Myalgia
Rare (less than 0.1%): Muscle spasm
Postmarketing reports: Rhabdomyolysis[Ref]
Metabolic
Common (1% to 10%): Hyperglycemia, hypertriglyceridemia, hyperuricemia, pseudohyperkalemia
Uncommon (0.1% to 1%): Hypercholesterolemia, hyperlipemia
Rare (less than 0.1%): Hyperkalemia[Ref]
Hepatic
Common (1% to 10%): GGT increased, AST increased, ALT increased, hepatic enzymes increased
Uncommon (0.1% to 1%): Bilirubinemia
Frequency not reported: Serum bilirubin elevated[Ref]
Genitourinary
Common (1% to 10%): Hematuria, impotence, urinary tract infection[Ref]
Psychiatric
Common (1% to 10%): Anxiety, insomnia[Ref]
Dermatologic
Common (1% to 10%): Hyperhidrosis
Uncommon (0.1% to 1%): Rash, exanthema, allergic dermatitis, urticaria, pruritus, face edema
Postmarketing reports: Alopecia[Ref]
Immunologic
Common (1% to 10%): Influenza
Uncommon (0.1% to 1%): Anaphylactic reaction
Rare (less than 0.1%): Angioedema[Ref]
Renal
Common (1% to 10%): Blood urea increased
Rare (less than 0.1%): Acute renal failure, renal insufficiency, blood creatinine increased[Ref]
Cardiovascular
Uncommon (0.1% to 1%): Tachycardia, angina pectoris
Rare (less than 0.1%): Hypotension[Ref]
Hematologic
Uncommon (0.1% to 1%): Thrombocytopenia
Frequency not reported: Small decreases in hemoglobin and hematocrit[Ref]
More about olmesartan
- Check interactions
- Pricing & coupons
- Reviews (190)
- Drug images
- Dosage information
- During pregnancy
- Drug class: angiotensin receptor blockers
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
References
1. "Product Information. Benicar (olmesartan)." Sankyo Pharma (2002):
2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
3. Cerner Multum, Inc. "Australian Product Information." O 0
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.